Mandatory Nicotine Cessation for Elective Orthopedic Hip Procedures Results in Reduction in Postoperative Nicotine Use

Nicotine Vaccines for Smoking Cessation

Cigarette smoking is the leading cause of preventable disease and death in the world. Smoking was responsible for an estimated 100 million deaths in the 20 century, and is expected to cause 10 times that number in the current century. A recent study estimated that smoking accounted for 16.6% of all deaths in Canada in 2002 – a total of 37,209 deaths. The direct and indirect costs of smoking in ...

Vaccines in trials for nicotine cessation therapy.

Three nicotine vaccines currently in clinical trials may offer alternatives to traditional pharmacologic smoking cessation therapy. Although the trial results are promising, these vaccines pose ethical questions and their role in clinical practice remains unclear.

Nicotine replacement therapy in smoking cessation.

Mecamylamine (a nicotine antagonist) for smoking cessation.

BACKGROUND Mecamylamine is a nicotine antagonist (that is it blocks the effect of nicotine). The rationale for its use in smoking cessation is that it may block the rewarding effect of nicotine and thus reduce the urge to smoke. OBJECTIVES The objective of this review was to determine the effectiveness of mecamylamine in promoting smoking cessation, either alone or in combination with nicotin...

Nicotine replacement for smoking cessation during pregnancy.

1. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005;434:1144-8. 2. Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010;24:1128-38. 3. Harrison C, Kiladjian J-J, Al-Ali HK, et al. JAK inhibition ...